BIOTECHNOLOGY  ENTREPRENEURSHIP

BOOT CAMP 2017

Created by Academia; Supported by Industry 

Founded in 2005 by Carnegie Mellon University & Wharton School Faculty

 

Dennis M. Gross, MS, PhD

CEO and Treasurer
Pennsylvania Drug Discovery Institute

Dennis M Gross, MS, PhD is the CEO and Treasurer of the Pennsylvania Drug Discovery Institute in Doylestown and King of Prussia, PA.  He is also Professor of Experimental Therapeutics and Medicinal Chemistry at the Baruch S. Blumberg Institute of the Hepatitis B Foundation and also Faculty in the Jefferson Graduate School of Biomedical Sciences (JGSBS) and the Sidney Kimmel Medical School of Thomas Jefferson University. Previously he was the Associate Dean of the JGSBS and Associate Professor of Pharmacology & Experimental Therapeutics in the Jefferson Medical College. Prior to this, he was at the Merck Research Labs (MRL) for 28 years retiring in 2006 as Senior Director and Head of West Point Business Operations with overall responsibilities for facilities in Pennsylvania, California and Massachusetts.  He was also responsible for capital laboratory projects and operations oversight at MRL sites in Canada, Japan, Italy and the UK.  In his career at MRL he held a number of positions ranging from bench scientist to head of computer resources, manager of international strategic planning, M&A activities and liaison for basic research and clinical drug development in Japan.

During his tenure at MRL, he also served as Adjunct Professor of Global Logistics in the School of Business and Industry of Florida A&M University. He has worked with the Center for Strategic & International Studies in Washington, DC on policy issues relating to biological weapons of mass destruction.  He received his BA and MS from California State University Northridge and his PhD from UCLA pursuing a postdoctoral fellowship at Tulane University School of Medicine. He has also participated in executive education programs at Wharton, MIT and the Tufts School of Law and received FEMA NIMS and ICS certification. He has been an active member of ISPE since 1996 and served as a Director at Large (2005-2009 and 2012-), a member of the R&D Subcommittee (2006-2013) and the recipient of the Buzz Lange Award in 2011. He is also a member of the American Chemical Society Medicinal Chemistry section, American Heart Association, History of Science Society, and Sigma Xi.